Gastric Cancer

Advanced treatment options for stomach cancer including surgery, chemotherapy, and targeted therapy.

Back to All Treatments
Gastric Cancer

Gastric Cancer

Solid Tumors

Overview

Gastric cancer treatment depends on stage, location, and molecular characteristics. Early-stage disease may be cured with surgery, while advanced disease requires multimodal therapy including chemotherapy, targeted therapy, and immunotherapy.

When to Consult

Upon diagnosis of gastric cancer, persistent indigestion, stomach pain, difficulty swallowing, or suspicious findings on endoscopy.

What to Bring

Endoscopy reports, biopsy results, CT scans, HER2 testing results, MSI/MMR testing, PD-L1 testing, and previous treatment records.

Risk Factors

Helicobacter pylori (H. pylori) infection
Diet high in salted, smoked, or pickled foods
Low fruit and vegetable intake
Smoking
Heavy alcohol use
Family history of gastric cancer
Previous stomach surgery
Pernicious anemia
Chronic atrophic gastritis
Adenomatous polyps
Age (risk increases with age)
Male gender
Blood type A
Genetic syndromes (Lynch syndrome, Li-Fraumeni)

Causes

H. pylori infection causing chronic inflammation
Dietary factors (nitrates, nitrites)
Genetic mutations (TP53, CDH1, HER2)
DNA damage from chronic inflammation
Epigenetic changes
Inherited genetic mutations
Environmental carcinogens
Gastric acid and pepsin exposure

Treatment Options

Gastrectomy

Subtotal gastrectomy (removal of part of stomach) or total gastrectomy (removal of entire stomach). May include lymph node dissection. Can be done laparoscopically or open surgery.

Neoadjuvant Chemotherapy

Chemotherapy before surgery (FLOT regimen: 5-FU, leucovorin, oxaliplatin, docetaxel) to shrink tumors and improve surgical outcomes. Standard for locally advanced disease.

Perioperative Chemotherapy

Chemotherapy before and after surgery. ECF/ECX or FLOT regimens. Improves survival compared to surgery alone.

Adjuvant Chemotherapy

Post-surgical chemotherapy (XELOX or S-1) to reduce recurrence risk. Based on stage and surgical margins.

HER2-Targeted Therapy

Trastuzumab combined with chemotherapy for HER2-positive gastric cancer. Pertuzumab may also be used. Targets HER2 protein overexpressed in some gastric cancers.

Immunotherapy

Pembrolizumab for MSI-high or PD-L1 positive advanced gastric cancer. Nivolumab combined with chemotherapy showing promise. May be first-line or later-line treatment.

Targeted Therapy

Ramucirumab (anti-VEGF) combined with paclitaxel for second-line treatment. Apatinib (VEGFR inhibitor) available in some regions.

Radiation Therapy

External beam radiation, often combined with chemotherapy (chemoradiation). May be used before surgery (neoadjuvant) or after (adjuvant), or for locally advanced unresectable disease.

Palliative Care

Symptom management including stenting for obstruction, pain management, nutritional support, and supportive care to improve quality of life.

Need Treatment?

Schedule a consultation to discuss treatment options for Gastric Cancer .